Cover Image
市場調查報告書

中國的組織工程皮膚替代品市場未來展望

China Tissue Engineered - Skin Substitutes Market Outlook to 2020

出版商 GlobalData 商品編碼 317777
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
中國的組織工程皮膚替代品市場未來展望 China Tissue Engineered - Skin Substitutes Market Outlook to 2020
出版日期: 2014年10月27日 內容資訊: 英文 41 Pages
簡介

本報告提供中國採用了組織工程(再生醫療)之皮膚替代品市場現狀與未來發展預測相關分析,提供您整體市場規模(以金額·數量為準)的實際成果值·預測值,及個別領域--生物學的皮膚替代品(培養皮膚),自體移植片(細胞/無細胞),合成/生物合成皮膚替代品,異質骨移植等--之詳細趨勢,市場價格趨勢,市場佔有率(各流通管道·各企業),主要企業的概要與策略等。

第1章 目錄

第2章 簡介

  • 本報告的問題意識
  • 組織工程皮膚替代品市場分類
  • 分析對像定義

第3章 中國的組織工程皮膚替代品市場

  • 市場規模的實際成果值(以金額為準,過去9年份)
  • 市場規模的預測值(以金額為準,今後8年份)
    • 生物學的皮膚替代品的市場規模:實際成果值(以金額為準,過去9年份)
    • 生物學的皮膚替代品的市場規模:預測值(以金額為準,今後8年份)
    • 自體移植片的市場規模:實際成果值(以金額為準,過去9年份)
    • 自體移植片的市場規模:預測值(以金額為準,今後8年份)
  • 市場規模的實際成果值(以數量為準,過去9年份)
  • 市場規模的預測值(以數量為準,今後8年份)
    • 生物學的皮膚替代品的市場規模:實際成果值(以數量為準,過去9年份)
    • 生物學的皮膚替代品的市場規模:預測值(以數量為準,今後8年份)
    • 自體移植片的市場規模:實際成果值(以數量為準,過去9年份)
    • 自體移植片的市場規模:預測值(以數量為準,今後8年份)
  • 平均價格趨勢(總計16年份)
  • 各流通管道的市場佔有率(以金額為準)
  • 各企業的市場佔有率(以金額為準)

第4章 主要企業概要

  • National Tissue Engineering Research Center
  • Integra LifeSciences Holdings Corporation
  • Smith. Nephew Plc
  • Covidien plc
  • BSN medical GmbH

第5章 附錄

圖表一覽

目錄
Product Code: GDMECC0944DB

GlobalData's new report, "China Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the China Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Tissue Engineered - Skin Substitutes market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market.
  • Global corporate-level profiles of key companies operating within the China Tissue Engineered - Skin Substitutes.
  • Key players covered include National Tissue Engineering Research Center., Integra LifeSciences Holdings Corporation and Smith & Nephew Plc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Tissue Engineered. Skin Substitutes Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Tissue Engineered. Skin Substitutes Market, China

  • 3.1. Tissue Engineered. Skin Substitutes Market, China, Revenue ($m), 2005-2013
  • 3.2. Tissue Engineered. Skin Substitutes Market, China, Revenue ($m), 2013-2020
    • 3.2.1. Biologic Skin Substitutes Market, China, Revenue ($m), by Segment, 2005-2013
    • 3.2.2. Biologic Skin Substitutes Market, China, Revenue ($m), by Segment, 2013-2020
    • 3.2.3. Allograft Market, China, Revenue ($m), by Sub Segment, 2005-2013
    • 3.2.4. Allograft Market, China, Revenue ($m), by Sub Segment, 2013-2020
  • 3.3. Tissue Engineered. Skin Substitutes Market, China, Volume (Units), 2005-2013
  • 3.4. Tissue Engineered. Skin Substitutes Market, China, Volume (Units), 2013-2020
    • 3.4.1. Biologic Skin Substitutes Market, China, Volume (Units), by Segment, 2005-2013
    • 3.4.2. Biologic Skin Substitutes Market, China, Volume (Units), by Segment, 2013-2020
    • 3.4.3. Allograft Market, China, Volume (Units), by Sub Segment, 2005-2013
    • 3.4.4. Allograft Market, China, Volume (Units), by Sub Segment, 2013-2020
  • 3.5. Tissue Engineered. Skin Substitutes Market, China, Average Price ($), 2005-2020
  • 3.6. Tissue Engineered. Skin Substitutes Market, China, Distribution Share by Revenue ($m), 2012-2013
  • 3.7. Tissue Engineered. Skin Substitutes Market, China, Company Share by Revenue ($m), 2012-2013

4. Overview of Key Companies in China, Tissue Engineered. Skin Substitutes Market

  • 4.1. National Tissue Engineering Research Center
    • 4.1.1. Company Overview
  • 4.2. Integra LifeSciences Holdings Corporation
    • 4.2.1. Company Overview
  • 4.3. Smith. Nephew Plc
    • 4.3.1. Company Overview
  • 4.4. Covidien plc
    • 4.4.1. Company Overview
  • 4.5. BSN medical GmbH
    • 4.5.1. Company Overview

5. Appendix

  • 5.1. Research Methodology
    • 5.1.1. Coverage
    • 5.1.2. Secondary Research
    • 5.1.3. Primary Research
    • 5.1.4. Market Modeling and Forecasting
    • 5.1.5. Company Share Analysis
    • 5.1.6. Distribution Share Analysis
  • 5.2. Expert Panel
  • 5.3. GlobalData Consulting
  • 5.4. Contact Us
  • 5.5. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 2: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 3: Biologic Skin Substitutes(Allograft) Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 4: Biologic Skin Substitutes (Allograft) Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 5: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Historic, 2005-2013
  • Table 6: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Forecast, 2013-2020
  • Table 7: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Historic, 2005-2013
  • Table 8: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Forecast, 2013-2020
  • Table 9: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Historic, 2005-2013
  • Table 10: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Forecast, 2013-2020
  • Table 11: Allograft Market, China, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Table 12: Allograft Market, China, Volume (Units), by Sub Segment, Forecast, 2013-2020
  • Table 13: Tissue Engineered - Skin Substitutes Market, China, Average Price ($), Historic, 2005-2013
  • Table 14: Tissue Engineered - Skin Substitutes Market, China, Average Price ($), Forecast, 2013-2020
  • Table 15: Tissue Engineered - Skin Substitutes Market, China, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 16: Tissue Engineered - Skin Substitutes Market, China, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 17: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 2: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 3: Biologic Skin Substitutes (Allograft) Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 4: Biologic Skin Substitutes (Allograft) Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 5: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Historic, 2005-2013
  • Figure 6: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Forecast, 2013-2020
  • Figure 7: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Historic, 2005-2013
  • Figure 8: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Forecast, 2013-2020
  • Figure 9: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Historic, 2005-2013
  • Figure 10: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Forecast, 2013-2020
  • Figure 11: Allograft Market, China, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Figure 12: Allograft Market, China, Volume (Units), by Sub Segment, Forecast, 2013-2020
  • Figure 13: Tissue Engineered - Skin Substitutes Market, China, Company Share (%), 2013
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top